Follow Us: social media social media social media    Language :           

New Publication: Reaksi Drug Safety News - Issue 3/2017

REAKSI Drug Safety News,

Issue 3/2017

 

  • Loperamide: Risk of Serious Cardiac Adverse Events with High Doses, Including Through Misuse
  • Thalidomide, Lenalidomide and Pomalidomide: Risk of Hepatitis B Reactivation, Herpes Zoster and Pulmonary Hypertension

 



 
 
  DOWNLOAD PDF


 

 

 

qrcode